Sunlife Pharmaceuticals Limited, a active public limited company, was established on 24 November 2009 in Kalyan, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74990MH2009PLC197290. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.57 M.
It upholds a compliant status. Its leadership includes Priyanka Devendra Mishra (Director), Devendra Harendranath Mishra (Director), Bachchalal Jaisingh Yadawa (Director). Past directors included Chandramohan Krishna Shetty, Sameer Sureshchandra Gholap, Radhasharan Gopiram Sharma. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 107, Globe Estate, Plot No C9, Midc Phase 1, New Kalyan Road, Dombivli (E), Thane, Maharashtra 421203, India, Kalyan, Maharashtra, 421203.
U74990MH2009PLC197290
197290
24 November 2009
₹1.00 M
₹0.57 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sunlife Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyanka Devendra Mishra | Director | 01 Apr 2016 | Current |
| Devendra Harendranath Mishra | Director | 01 Apr 2016 | Current |
| Bachchalal Jaisingh Yadawa | Director | 12 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2016 | Past |
| Pramod Abcsdd | Director | 18 Aug 2011 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sunlife Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 126.98% increase. The company also saw a slight improvement in profitability, with a 5.08% increase in profit. The company's net worth moved up by a moderate rise of 3.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sunlife Pharmaceuticals had a promoter holding of 85.01% and a public holding of 14.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sunlife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sunlife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunlife Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sunlife Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Sunlife Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Bachchalal Jaisingh Yadawa was appointed as a Director was appointed as a Director on 12 Jan 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Priyanka Devendra Mishra was appointed as a Director was appointed as a Director on 01 Apr 2016 & has been associated with this company since 9 years 8 months . was recorded as a recent event.
The activity Devendra Harendranath Mishra was appointed as a Director was appointed as a Director on 01 Apr 2016 & has been associated with this company since 9 years 8 months . was completed.
Progress on Sunlife Pharmaceuticals Limited was registered on 24 Nov 2009 with Roc Mumbai & aged 16 years 8 days as per MCA records. was documented.
The CIN of Sunlife Pharmaceuticals Limited is U74990MH2009PLC197290.
Sunlife Pharmaceuticals Limited is headquartered at 107, Globe Estate, Plot No C9, Midc Phase 1, New Kalyan Road, Dombivli (E), Thane, Maharashtra 421203, India, Kalyan, Maharashtra, 421203.
Sunlife Pharmaceuticals Limited was incorporated on 24 November 2009.
The current directors of Sunlife Pharmaceuticals Limited are
The primary industry of Sunlife Pharmaceuticals Limited is Trade.
Sunlife Pharmaceuticals Limited is unlisted.
The authorized capital of Sunlife Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹0.57 M.
The compliance status of Sunlife Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX